9:22 AM
Leo Group India
| ||
| Thomson Reuters Annual Pharmaceutical Factbook Reveals Key ... Reuters Fewer projects with higher success rates show focus on quality paying off London, UK, 26 June 2012 - The In. See all stories on this topic » | ||
| NPS Pharmaceuticals Launches Educational Website on ... MarketWatch (press release) NPS Pharmaceuticals is a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options. See all stories on this topic » | ||
| European Pharmaceutical Leader Gedeon Richter Selects Psion ... MarketWatch (press release) "The business features of this rugged device make it the ideal tool for the pharmaceutical industry, offering workers access to robust and accurate information, ... See all stories on this topic » | ||
| Hot Stocks: Arena Pharmaceuticals, Teva, Cemex, Occidental ... MarketWatch (press release) Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) : In the last trading session, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) slipped 6.93% to US$9.19, which was ... See all stories on this topic » | ||
| Pharmaceutical exports estimated to reach $82b China Daily By 2015, the annual exports of the pharmaceutical industry will reach $82 billion, with an annual growth rate of over 20 percent, reported Shanghai Securities ... See all stories on this topic » | ||
| The Zacks Analyst Blog Highlights: Teva Pharmaceutical, Momenta ... Sacramento Bee PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ... See all stories on this topic » | ||
| Presidio Pharmaceuticals Successfully Completes Phase 1 Proof-of ... MarketWatch (press release) Presidio Pharmaceuticals Successfully Completes Phase 1 Proof-of-Concept for PPI-668, its Potent HCV NS5A Inhibitor, in Hepatitis C Patients with Genotype-1 ... See all stories on this topic » | ||
| Natco loses US patent suit by Israeli pharma major Teva Economic Times India's Natco Pharma has lost a patent infringement suit in the US filed by Israeli pharma major Teva over sale of Copaxone, a drug used to treat multiple ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment